Skip to main navigation Skip to search Skip to main content

APOL1 C-terminal variants may trigger kidney disease through interference with APOL3 control of actomyosin

  • Sophie Uzureau
  • , Laurence Lecordier
  • , Pierrick Uzureau
  • , Dorle Hennig
  • , Jonas H. Graversen
  • , Fabrice Homble
  • , Pepe Ekulu Mfutu
  • , Fanny Oliveira Arcolino
  • , Ana Raquel Ramos
  • , Rita M. La Rovere
  • , Tomas Luyten
  • , Marjorie Vermeersch
  • , Patricia Tebabi
  • , Marc Dieu
  • , Bart Cuypers
  • , Stijn Deborggraeve
  • , Marion Rabant
  • , Christophe Legendre
  • , Soren K. Moestrup
  • , Elena Levtchenko
    • Geert Bultynck, Christophe Erneux, David Perez-Morga, Etienne Pays

Research output: Contribution to journal › A1: Peer-reviewed journal articles › peer-review

79 Downloads (Pure)

Fingerprint

Dive into the research topics of 'APOL1 C-terminal variants may trigger kidney disease through interference with APOL3 control of actomyosin'. Together they form a unique fingerprint.
Sort by

Biochemistry, Genetics and Molecular Biology

Medicine and Dentistry